Search
Xenon Pharmaceuticals Inc
XENEAdd to Watchlist
62.670USD
-1.520-2.37%
Close 07-31 16:00（ET）Quotes delayed by 15 min
6.06BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Xenon Pharmaceuticals Inc is 8.90, ranking 38 out of 385 in the Biotechnology & Medical Research industry. The average price target is 55.00, with a high of 65.00 and a low of 44.00.
Analyst Rating
Based on
20
analysts
Buy
Current Rating
80.118
Target Price
+26.97%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Xenon Pharmaceuticals Inc
XENE
20
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
26
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
25
Kymera Therapeutics Inc
KYMR
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Xenon Pharmaceuticals Inc's expected revenue for the next quarter?
Xenon Pharmaceuticals Inc's expected revenue is 1.25M.
What is Xenon Pharmaceuticals Inc's price target?
Analysts forecast that Xenon Pharmaceuticals Inc's price target is USD 55.00, with the highest forecast at USD 65.00 and the lowest forecast at USD 44.00.
How have Xenon Pharmaceuticals IncXENE's recent earnings per share performed?
The market expectation was USD -1.17, while Xenon Pharmaceuticals IncXENE's earnings per share (EPS) for the previous quarter was USD -1.31. EPS for the next quarter is expected at USD -1.14.
What is the analyst rating for Xenon Pharmaceuticals Inc?
Based on the ratings of Xenon Pharmaceuticals Inc's stock from 20 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.